Press Releases

WASHINGTON, Nov. 27 – In a letter sent Monday to Senate Majority Leader Mitch McConnell (R-Ky.) and House Speaker Paul Ryan (R-Wisc.), Sen. Bernie Sanders (I-Vt.) demanded honesty from the Republican leaders as to how they would pay for the $1.4 trillion deficit in their “tax reform” bills. “I am very concerned that if you succeed in passing tax legislation

BURLINGTON, Vt., Nov. 17 – U.S. Sen. Bernie Sanders (I-Vt.) held a student town meeting Friday with the entire student body of Burlington High School and the Burlington Technical Center to discuss the opioid crisis in Vermont and throughout the United States.   “I need your help. Not only for Vermont, but for the entire country,” Sanders told the students. “It

BURLINGTON, Vt., Nov. 17 – U.S. Sen. Bernie Sanders (I-Vt.) issued the following statement Friday after the White House asked Congress for $44 billion in additional disaster relief for areas ravaged by hurricanes Harvey, Irma and Maria: “The president’s request for supplemental appropriations for disaster relief is totally inadequate. While the president wants to provide the very richest people in this country

BURLINGTON, Nov. 16 – U.S. Sen. Bernie Sanders (I-Vt.) released the following statement Thursday on Sen. Franken: “Sexual harassment is completely unacceptable. I agree with the calls for an Ethics Committee investigation into this deeply troubling incident.”

WASHINGTON, Nov. 16 – Sen. Bernie Sanders (I-Vt.) issued the following statement Thursday after the House passed its version of the Republican tax overhaul: “It is disappointing, but not surprising that the House Republicans just voted to give the Koch brothers and other billionaire campaign contributors a massive tax break. Under the House bill, the top 1 percent would get

WASHINGTON, Nov. 13 – Sen. Bernie Sanders (I-Vt.) issued the following statement after President Donald Trump nominated Alex Azar to be secretary of health and human services: “At a time when the United States pays, by far, the highest prices in the world for prescription drugs, the last thing we need is to put a pharmaceutical executive in charge of